申请人:Li Hui
公开号:US20100190770A1
公开(公告)日:2010-07-29
Disclosed are compounds of formula I, compositions containing them, and methods of use for the compounds and compositions in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK 2 and JAK3, are therapeutically useful.
公开了化合物I的结构,含有这些化合物的组合物,以及在治疗需要调节JAK途径或抑制JAK激酶,特别是JAK 2和JAK3的情况下使用这些化合物和组合物的方法。